Pfizer Inc Stock Price on May 9, 2019
PFE Stock | USD 27.75 0.03 0.11% |
Below is the normalized historical share price chart for Pfizer Inc extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pfizer stands at 27.75, as last reported on the 29th of March, with the highest price reaching 28.12 and the lowest price hitting 27.72 during the day.
If you're considering investing in Pfizer Stock, it is important to understand the factors that can impact its price. Pfizer Inc maintains Sharpe Ratio (i.e., Efficiency) of -0.0585, which implies the firm had a -0.0585% return per unit of risk over the last 3 months. Pfizer Inc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pfizer's Coefficient Of Variation of (42,006), risk adjusted performance of 0.0046, and Variance of 1.89 to confirm the risk estimate we provide.
At present, Pfizer's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to 0.00, whereas Other Stockholder Equity is projected to grow to (20.8 B). . At present, Pfizer's Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 22.13, whereas Price Earnings To Growth Ratio is projected to grow to (0.78). Pfizer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of August 2012 | 200 Day MA 31.6712 | 50 Day MA 27.47 | Beta 0.557 |
Pfizer |
Sharpe Ratio = -0.0585
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PFE |
Estimated Market Risk
1.36 actual daily | 12 88% of assets are more volatile |
Expected Return
-0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pfizer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pfizer by adding Pfizer to a well-diversified portfolio.
Price Book 1.7672 | Enterprise Value Ebitda 22.5448 | Price Sales 2.6964 | Shares Float 5.6 B | Dividend Share 1.64 |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CLSK | CleanSpark | |
V | Visa Class A | |
CDLX | Cardlytics |
About Pfizer Stock history
Pfizer investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pfizer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pfizer Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pfizer stock prices may prove useful in developing a viable investing in Pfizer
Last Reported | Projected for 2024 | ||
Common Stock Shares Outstanding | 5.7 B | 6.3 B | |
Net Income Applicable To Common Shares | 36.1 B | 37.9 B |
Pfizer Stock Technical Analysis
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pfizer Period Price Range
Pfizer March 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pfizer shares will generate the highest return on investment. By undertsting and applying Pfizer stock market strength indicators, traders can identify Pfizer Inc entry and exit signals to maximize returns
Accumulation Distribution | 575327.0 | |||
Daily Balance Of Power | (0.07) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 27.92 | |||
Day Typical Price | 27.86 | |||
Price Action Indicator | (0.19) | |||
Period Momentum Indicator | (0.03) |
Pfizer Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pfizer's price direction in advance. Along with the technical and fundamental analysis of Pfizer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pfizer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0046 | |||
Jensen Alpha | (0.1) | |||
Total Risk Alpha | (0.32) | |||
Treynor Ratio | (0.02) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.